Protein Shield: How Damaged Cells Evade Immune Detection During Aging

Researchers at Cedars-Sinai identified PD-L2, a protein that enables senescent cells to escape immune removal and accumulate in tissues with age. In studies, blocking this protein reduced the buildup of damaged cells in older mice and improved insulin sensitivity and physical strength. The findings suggest PD-L2 could serve as both a treatment target to clear harmful aging cells and a potential blood marker for tracking them.

Senescent cells represent a significant challenge in aging biology. These are cells that have sustained damage and ceased their normal division cycle, yet persist within tissues rather than being eliminated. Once present, they actively contribute to age-related decline by secreting inflammatory molecules that harm surrounding healthy cells, creating a cascade of dysfunction throughout the body.

The discovery of PD-L2's role provides insight into an immune evasion mechanism. This protein appears to function as a "shield" that suppresses the immune system's ability to recognize and remove these damaged cells. The research demonstrated that higher PD-L2 levels correlate with cellular aging, suggesting the protein becomes increasingly prevalent as organisms grow older, potentially explaining the progressive accumulation of senescent cells during the aging process.